Evidence map›Paper›PMID 31581974›Full record

ArticleComparative medicine2019

Pharmacokinetics of Ertapenem in Sheep (

Joe S Smith, David J Borts, Clare C Slagel, Suzanne M Rajewski, Alain Bousquet-Melou, Aude A Ferran, Paul J Plummer, Jon P Mochel

Abstract read
In one paragraph

Article in Comparative medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Urinary tract infections and catheter-associated urinary tract infections caused byMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  2. Pharmacokinetics of esomeprazole in goats (Frontiers in veterinary science · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Joe S SmithVeterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa: Systems Modelling and Reverse Translational (SMART) Pharmacology, Iowa State University, Ames, Iowa;, Email: jss303@iastate.edu.
David J BortsVeterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa.
Clare C SlagelAnalytical Chemistry Services, Iowa State University, Ames, Iowa.
Suzanne M RajewskiAnalytical Chemistry Services, Iowa State University, Ames, Iowa.
Alain Bousquet-MelouINTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
Aude A FerranINTHERES, Université de Toulouse, INRA, ENVT, Toulouse, France.
Paul J PlummerVeterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa; Veterinary Microbiology and Preventative Medicine, Iowa State University, Ames, Iowa; National Institute of Antimicrobial Resistance Research and Education, Ames, Iowa.
Jon P MochelVeterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, Iowa; Systems Modelling and Reverse Translational (SMART) Pharmacology, Iowa State University, Ames, Iowa.
Iowa State University · USÉcole Nationale Vétérinaire de Toulouse · FRUniversité de Toulouse · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sheep are commonly used as animal models for human biomedical research, but descriptions of their use for studying the pharmacokinetics of carbapenem antimicrobials, such as ertapenem, are unavailable. Ertapenem is a critical antimicrobial for human infections, and the description of the pharmacokinetics of this drug is of value for research using ovine as models for human diseases, such as urinary tract infections (UTI). There are currently no ovine models for comparative biomedical research of UTI. The objective of this study was to report the pharmacokinetics of ertapenem in sheep after single and multiple dosing. In addition, we explored the effects of an immunomodulatory drug (Zelnate) on the pharmacokinetics of ertapenem in sheep. Eight healthy ewes (weight, 64.4 ± 7.7 kg) were used in an ovine bacterial cystitis model of human cystitis with

Indexed as

Disease Models, AnimalSheepAnimalsAnti-Bacterial AgentsErtapenemHumansPseudomonas aeruginosaUrinary Tract InfectionsAnti-Bacterial AgentsErtapenem

Identifiers

PMID31581974
PMCPMC6807722
OpenAlexW2978015731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.